Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE approves lung cancer combination drug therapy for NHS use

Pharmaceutical-TechnologyJanuary 14, 2022

Tag: pembrolizumab , NICE , lung cancer

PharmaSources Customer Service